return to small text site

 

US
Europe
US
Europe

press releases

press coverage
electronic press kit
Luveniq

LX214

LX212
proprietary technologies
pipeline

uveitis

dry eye syndrome

age-related macular degeneration

history
management
board of directors

investors

About

Ophthalmic Indications
Products &
Technologies

Partners

News & Media
Careers
Contact Us

 

  ABOUT LUX
 

Lux Biosciences is a clinical stage biotechnology company specializing in the development and commercialization of innovative medications for serious ophthalmic diseases. With a first-in-class product in NDA/MAA submission stage and several exciting earlier-stage projects, Lux is building a revenue-generating, high-growth, and sustainable ophthalmic company.

 

© 2009 Lux Biosciences, Inc. All rights reserved.                 Web Terms